Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer. - Wikidata - awgldk - TriplyDB

Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer.

Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer.

http://www.wikidata.org/entity/Q37591955

about

Emerging molecular basis of hematogenous metastasis in gastric cancer Trial Watch: Peptide-based anticancer vaccines.Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer.Vaccination with a Paramyosin-Based Multi-Epitope Vaccine Elicits Significant Protective Immunity against Trichinella spiralis Infection in Mice.Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development.A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer.Immunotherapy for Gastric Cancer: Time for a Personalized Approach?Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer

P2860

Q26764924-C93EE360-2D89-4196-9119-48B6A417BD9E Q34483345-1A55F515-2944-471E-BE73-E8B25C875E97 Q35713347-479F9EC2-0337-4DB1-9612-E40FC359BCB7 Q39034918-B8D1F61D-B665-4F22-AADA-ACD60155218C Q41110505-A0CCF46F-ABC1-4707-BEAC-542B30A3F0A0 Q55227468-7A34676B-4C56-4F9B-963C-82F0C46FC01F Q55652343-203FDBBC-D1C8-437E-B89C-80C1F9437D6C Q57167306-1FC365A4-F2B8-4F45-9091-99D49F1BE54D

P2860

Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer.

http://www.wikidata.org/entity/Q37591955

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Phase I clinical trial of pept ...... with advanced gastric cancer.

@en

Phase I clinical trial of pept ...... with advanced gastric cancer.

@nl

type

label

Phase I clinical trial of pept ...... with advanced gastric cancer.

@en

Phase I clinical trial of pept ...... with advanced gastric cancer.

@nl

prefLabel

Phase I clinical trial of pept ...... with advanced gastric cancer.

@en

Phase I clinical trial of pept ...... with advanced gastric cancer.

@nl

P1433

Q37591955-71F5D33F-C138-410E-96DB-5C6FE33B1EEA

P1476

Q37591955-D12EE5F5-1C19-4ADE-AB42-88F513B9CF5F

P2093

Q37591955-00E28588-A78A-47B3-BD03-28899F9702AD

Q37591955-0B3CFEDA-ED88-4F1B-B6F4-7493B1BBE4DC

Q37591955-1AB70A53-E551-4F3B-A9E0-C23F00A3EBAE

Q37591955-51903726-1864-44BC-86B3-E967093A688D

Q37591955-80D408EF-E646-4E22-AD0C-24D6D32251D8

Q37591955-926E331B-C032-44A6-9B13-EBEE16A23746

Q37591955-9E4E314C-577A-4C51-B596-61B6B0B1C3B4

Q37591955-E36E3F58-7C0A-43C0-A57B-E8914EC2B103

Q37591955-F12A12A1-C090-4EEF-B310-CD3C2ADBDD0C

P2860

Q37591955-0C8012A8-5A85-43BD-83D5-BAB455F86DCC

Q37591955-22B17800-C2C8-43C1-A4F2-AE014170CCAD

Q37591955-411F5582-9F49-4279-BD93-9A81C5A59046

Q37591955-58FA9B74-F284-48D6-96FB-2860DB8AC04A

Q37591955-726B992A-0A2F-407B-8D97-875BBBF3658F

Q37591955-734CA7D0-E19A-4DB5-8117-A676710C67E4

Q37591955-8606513B-97A8-4FA9-82A4-E31F393469A7

Q37591955-8BABE0EF-7C7E-49FE-ABD2-233325E204A1

Q37591955-916D20F1-D59B-4A52-B624-A870AD22454A

Q37591955-930E0472-600F-44CA-A901-33B84B68736D

P304

Q37591955-F9F73C24-0360-46D4-89D0-EA755FADF9D5

P31

Q37591955-9A3DDDD0-7513-4907-8563-ADD40EB5170D

P356

Q37591955-9C105953-F773-4626-8584-3BB9E833054E

P433

Q37591955-C660D745-BE84-436D-940D-E344654B13C4

P478

Q37591955-3718DA4E-731D-4FE8-9420-0764135ECD2B

P577

Q37591955-B88767AE-7FE5-4BFD-99F3-54887EF03906

P5875

Q37591955-68ED280F-FE26-44B3-930A-85735C45BC47

P698

Q37591955-7CE377F8-EC0F-464B-80BC-C28E7ED4D601

P921

Q37591955-F3B33A66-E5C3-4057-99A8-E923BB75E93A

P932

Q37591955-6455A318-0CD4-4E0D-B027-69B7FBB11A15

P356

P1433

International Journal of Oncology

P1476

Phase I clinical trial of pept ...... with advanced gastric cancer.

@en

P2093

Akihito Nagahara

http://www.w3.org/2001/XMLSchema#string

Junko Kato

http://www.w3.org/2001/XMLSchema#string

Kentaro Izumi

http://www.w3.org/2001/XMLSchema#string

Masae Konishi

http://www.w3.org/2001/XMLSchema#string

Nobuko Serizawa

http://www.w3.org/2001/XMLSchema#string

Sumio Watanabe

http://www.w3.org/2001/XMLSchema#string

Taro Osada

http://www.w3.org/2001/XMLSchema#string

Tomohiro Kodani

http://www.w3.org/2001/XMLSchema#string

Yoshie Higashihara

http://www.w3.org/2001/XMLSchema#string

P2860

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Identification of TOMM34, which shows elevated expression in the majority of human colon cancers, as a novel drug target.

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination.

Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens.

Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma.

Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.

Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma.

Identification of immunoglobulin superfamily 11 (IGSF11) as a novel target for cancer immunotherapy of gastrointestinal and hepatocellular carcinomas.

P304

662-668

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/IJO.2013.2242

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259627364

http://www.w3.org/2001/XMLSchema#string

P698

24398900

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

P932

3928476

http://www.w3.org/2001/XMLSchema#string